Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 10/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30212085 | 0.96 | FASN (0.66) | FASNMEN1KMT2APAK1PTGES | |
| SCHEMBL30212080 | 0.94 | FASN (0.66) | FASNMEN1KMT2APAK1PTGES | |
| Desaspidin SCHEMBL2732746 | 0.89 | FASN (0.51) | FASNMEN1KMT2APAK1PTGES | |
| Desaspidin SCHEMBL29613713 | 0.89 | FASN (0.51) | FASNMEN1KMT2APAK1PTGES | |
| SCHEMBL30212097 | 0.86 | FASN (0.59) | FASNMEN1KMT2APAK1HMGCR | |
| SCHEMBL30212088 | 0.84 | FASN (0.72) | FASNPTGESALOX5FFAR1PLA2G2A | |
| SCHEMBL30212066 | 0.82 | FASN (0.72) | FASNPTGESALOX5FFAR1PLA2G2A | |
| SCHEMBL30212065 | 0.82 | FASN (0.72) | FASNPTGESALOX5FFAR1PLA2G2A | |
| SCHEMBL30212078 | 0.80 | FASN (0.63) | FASNPTGESALOX5PLA2G2APLA2G5 | |
| Desaspidin SCHEMBL28086151 | 0.80 | FASN (0.42) | FASNMEN1KMT2APAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |